UK Key To Cost Effective Prescribing

24 July 1994

Health authorities have an important role to play in ensuring that doctors prescribe cost-effectively and clinically-effectively, UK Health Minister Brian Mawhinney told a conference on prescribing for purchasers' authorities.

Earlier this year, he said, the UK Audit Commission report pointed out that, although there is much good prescribing in the country, over L400 million ($628.6 million) could be saved if all general practitioners prescribed as responsibly as 50 model practices (Marketletter March 14). "With the drug bill currently standing at L3 billion and rising," he said, "health authorities can play their part in promoting cost-effective and clinically-effective prescribing."

Prescribing activities of hospitals also have an impact on around a third of the primary care drugs bill, Dr Mawhinney said, and if to this is added the fact that "a significant number of hospital admissions are caused by the ill effects of drug treatment, be it interactions or patients not taking the drugs prescribed, it is clear that good prescribing is very much a key issue for purchasers."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight